Nasdaq: MNPR
Monopar Therapeutics insiders
The officers, directors and 10% owners of Monopar Therapeutics Inc. who hold the most stock, valued at the live MNPR price.
$70.29
MNPR today −$460K (−0.65%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their MNPR stock
- $138M
- Market value
- $476M
- Held by ranked insiders
- 28.9%
Insiders by value of MNPR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Andrew Paul Mazar | Chief Scientific Officer | 860,013 | $60.5M | 12.7% | 2224th |
| 2 | Diane Hendricks | 10% owner | 661,330 | $46.5M | 9.76% | 2676th |
| 3 | Michael J. Brown | Insider | 272,026 | $19.1M | 4.01% | 1107th |
| 4 | Chandler Robinson | Chief Executive Officer | 166,942 | $11.7M | 2.46% | 7793rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Monopar Therapeutics; see each profile for the filing.